跳轉至內容
Merck
全部照片(1)

Key Documents

SML1617

Sigma-Aldrich

GSK2033

≥98% (HPLC)

同義詞:

2,4,6-三甲基-N-[[3′-(甲基磺酰基)[1,1′-联苯]-4-基]甲基]-N-[[5-(三氟甲基)-2-呋喃基]甲基]苯磺酰胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C29H28F3NO5S2
CAS號碼:
分子量::
591.66
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 3 mg/mL, clear (warmed)

儲存溫度

2-8°C

SMILES 字串

CS(C1=CC=CC(C2=CC=C(CN(S(C3=C(C)C=C(C)C=C3C)(=O)=O)CC4=CC=C(C(F)(F)F)O4)C=C2)=C1)(=O)=O

InChI

1S/C29H28F3NO5S2/c1-19-14-20(2)28(21(3)15-19)40(36,37)33(18-25-12-13-27(38-25)29(30,31)32)17-22-8-10-23(11-9-22)24-6-5-7-26(16-24)39(4,34)35/h5-16H,17-18H2,1-4H3

InChI 密鑰

PSOXOVKYGWBTPB-UHFFFAOYSA-N

生化/生理作用

GSK2033具有抑制GC(糖皮质激素)刺激的糖异生基因表达的能力,而不会改变免疫反应性GR(GC受体)靶基因。它有助于靶向可以改变肝基因表达的几种核受体。
GSK2033是核受体肝X受体(LXR)的拮抗剂,LXRα的pIC50值为7.0,LXRβ的pIC50值为7.4。用GSK2033处理鼠CD41 T细胞可增强细胞增殖和Th1/Th2/Th17分化。在另一项研究中,通过与GSK2033预孵育,完全消除了共轭亚油酸(CLA)诱导的外排蛋白ATP结合盒转运蛋白A1(ABCA1)的表达,表明CLA介导的ABCA-1表达调控是LXR依赖性的。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease.
Griffett K and Burris TP
Biochemical and Biophysical Research Communications, 479(3), 424-428 (2016)
Separating the Anti-Inflammatory and Diabetogenic Effects of Glucocorticoids Through LXRβ Antagonism.
Patel R, et al.
Endocrinology, 158(4), 1034-1047 (2017)
Lili Chen et al.
Journal of neurochemistry, 154(2), 205-217 (2019-10-12)
Cerebral ischemia (CI) leads to cognitive dysfunction due to the loss of hippocampal neurons. Liver X receptors (LXRs), including the LXRα and LXRβ isoforms, are critical for neurogenesis, synaptic plasticity, neurodegeneration, and cholesterol metabolism. However, the potential role of LXRs
Louise Ménégaut et al.
Cell reports, 31(7), 107665-107665 (2020-05-21)
Low-grade inflammation is constitutive of atherosclerosis, and anti-inflammatory therapy inhibiting interleukin-1β (IL-1β) reduces the rate of cardiovascular events. While cholesterol accumulation in atheroma plaque and macrophages is a major driver of the inflammatory process, the role of the LXR cholesterol

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務